Maximal androgen blockade for patients with metastatic prostate cancer: Outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy

Paul Schellhammer, Roohollah Sharifi, Norman Block, Mark S Soloway, Peter Venner, A. Lynn Patterson, Michael Sarosdy, Nicholas Vogelzang, Julie Jones, Geert Kolvenbag

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint Dive into the research topics of 'Maximal androgen blockade for patients with metastatic prostate cancer: Outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences